Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer

BJU International

Volumn 107, Issue 7, 2011, Pages 1069-1073

  Szarvas, Tibor ^a,c   Singer, Bernhard B ^a   Becker, Markus ^a   Vom Dorp, Frank ^a   Jäger, Tobias ^a   Szendråi, Attila ^b   Riesz, Péter ^b   Romics, Imre ^b   Rübben, Herbert ^a   Ergün, Süleyman ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

bladder cancer; matrilysin; metastasis; MMP 7; prognosis; urine

Indexed keywords

MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REGIONAL METASTASIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; URINALYSIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 78549286948     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09625.x     Document Type: Article

References (19)

1. Shiomi T, Okada Y,. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003; 22: 145-52 (Pubitemid 36561054)
2. Yamamoto H, Adachi Y, Itoh F, et al,. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999; 59: 3313-6 (Pubitemid 29334482)
3. Adachi Y, Yamamoto H, Itoh F, et al,. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 2001; 95: 290-4 (Pubitemid 32847038)
4. Yamamoto H, Itoh F, Adachi Y, et al,. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 1997; 112: 1290-6 (Pubitemid 27157543)
5. Yamamoto H, Iku S, Adachi Y, et al,. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003; 199: 176-84 (Pubitemid 36176023)
6. Yamamoto H, Itoh F, Iku S, et al,. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 2001; 19: 1118-27 (Pubitemid 32176289)
7. Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H,. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 2006; 12: 6998-7003 (Pubitemid 44974495)
8. Jones LE, Humphreys MJ, Campbell F, Neoptolemos JP, Boyd MT,. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004; 10: 2832-45 (Pubitemid 38509163)
9. Maurel J, Nadal C, Garcia-Albeniz X, et al,. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 2007; 121: 1066-71 (Pubitemid 47101644)
10. Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Jung K,. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas. Cancer Sci 2008; 99: 1188-94 (Pubitemid 351676631)
11. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 (Pubitemid 40372904)
12. vom Dorp F, Börgermann C, Schenck M, et al,. Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder. Urologe A 2009; 48: 51-3
13. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75 (Pubitemid 32120143)
14. Persad R, Kabala J, Gillatt D, Penry B, Gingell JC, Smith PJ,. Magnetic resonance imaging in the staging of bladder cancer. Br J Urol 1993; 71: 566-73 (Pubitemid 23172053)
15. Szarvas T, Becker M, vom Dorp F, et al,. Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer. Cancer Sci 2010; 101: 1300-8
16. Eble JN, Epstein JI, Sesterhenn I,. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon: IARCC Press, 2004: 89-158
17. Prout G, Marshall VF,. The prognosis with untreated bladder tumors. Cancer 1956; 9: 551-8
18. Kioi M, Yamamoto K, Higashi S, Koshikawa N, Fujita K, Miyazaki K,. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 2003; 22: 8662-70 (Pubitemid 38010489)
19. Zeng ZS, Shu WP, Cohen AM, Guillem JG,. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 2002; 8: 144-8 (Pubitemid 34101470)